Longevity eye cream
US-2024423898-A1 · Dec 26, 2024 · US
US10456353B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10456353-B2 |
| Application number | US-201515304130-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 1, 2015 |
| Priority date | Apr 17, 2014 |
| Publication date | Oct 29, 2019 |
| Grant date | Oct 29, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a personal care composition which provides enhanced inter-cellular tight junction in skin cells. The invention more particularly relates to use of such composition for application on skin, scalp, hair and oral cavity. The personal care composition comprises an extract of Aloe vera and a hyaluronic acid polymer having a molecular weight from 5 to 60 kDa.
Opening claim text (preview).
The invention claimed is: 1. A personal care composition comprising (i) an extract of Aloe vera; and (ii) a hyaluronic acid polymer having a molecular weight from 5 to 60 kDa, the hyaluronic acid having the monomeric structure; wherein the extract of Aloe vera comprises 60 to 95% by weight of hydrolysed polysaccharides having a molecular weight in the range of 2 to 3 kDa and 0.1 to 20% by weight polyphenols. 2. A composition as claimed in claim 1 wherein the extract of Aloe vera comprises about 0.1 to 2% by weight polyphenols. 3. A composition as claimed in claim 1 comprising higher than 30% by weight of polysaccharide comprising the polymer backbone 4. A composition as claimed in claim 1 wherein the hyaluronic acid polymer has a molecular weight from 45 KDa to 55 kDa. 5. A composition as claimed in claim 1 comprising about 0.05 to 10% by weight extract of Aloe vera. 6. A composition as claimed in claim 1 comprising about 0.05 to 5% by weight extract of Aloe vera. 7. A composition as claimed in claim 1 comprising about 0.1 to 10% by weight hyaluronic acid polymer. 8. A composition as claimed in claim 1 comprising about 0.1 to 5% by weight hyaluronic acid polymer. 9. A composition of claim 1 further comprising a cosmetically acceptable base comprising a fatty acid, fatty acid salt, natural or synthetic polymer, water, calcium carbonate, silica, orally acceptable surfactant, or a combination of two or more thereof. 10. A composition as claimed in claim 9 , wherein the composition comprises about 0.1 to 5% by weight of the hyaluronic acid polymer; about 0.05 to 5% by weight of the extract of Aloe vera; and about 50 to 99% by weight of the cosmetically acceptable base; wherein: the extract of Aloe vera comprises about 91 to 95% by weight of hydrolysed polysaccharides and about 0.1 to 5% by weight polyphenols; and the cosmetically acceptable base comprises water. 11. A composition as claimed in claim 10 , wherein the composition comprises about 0.05 to 0.1% by weight of the extract of Aloe vera. 12. A composition as claimed in claim 10 , wherein the the extract of Aloe vera comprises about 0.1 to 2% by weight polyphenols. 13. A composition as claimed in claim 10 , wherein the composition comprises about 85 to 99% by weight of the cosmetically acceptable base. 14. A method of providing enhanced immunity to an external surface of a human or animal body comprising applying the composition of claim 1 to the external surface of the human or animal body, wherein the immunity of the external surface after applying the composition is greater than the immunity of the external surface after applying the extract of Aloe vera alone to the external surface or after applying the hyaluronic acid polymer alone to the external surface, wherein immunity is measured by trans epithelial electrical resistance (TEER). 15. The method of claim 14 , wherein the immunity of the external surface after applying the composition is synergistic compared to immunity provided by the extract of Aloe vera alone and immunity provided by the hyaluronic acid polymer alone. 16. A method of providing enhanced immunity to an external surface of a human or animal body comprising applying the composition of claim 10 to the external surface of the human or animal body, wherein the immunity of the external surface after applying the composition is greater than the immunity of the external surface after the extract of Aloe vera is applied alone to the external surface or after the hyaluronic acid polymer is applied alone to the external surface, wherein immunity is measured by trans epithelial electrical resistance. 17. The method of claim 16 , wherein the immunity of the external surface after applying the composition is synergistic compared to immunity provided by the extract of Aloe vera alone and immunity provided by the hyaluronic acid polymer alone.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Immunostimulants · CPC title
Liliopsida [monocotyledons] · CPC title
Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof · CPC title
Antidandruff preparations · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.